Literature DB >> 20539019

Human vascular smooth muscle cells lack essential costimulatory molecules to activate allogeneic memory T cells.

Pei Zhang1, Thomas D Manes, Jordan S Pober, George Tellides.   

Abstract

OBJECTIVE: The arterial media, populated by vascular smooth muscle cells (VSMC), is an immunoprivileged compartment and, in contrast to the intima or adventitia containing endothelial cells, is generally spared by inflammatory processes, such as arteriosclerosis. To determine mechanisms of medial immunoprivilege, we investigated the ability of human VSMC versus endothelial cells to activate allogeneic T cells in vitro. METHODS AND
RESULTS: Unlike cultured endothelial cells, cultured VSMC do not activate allogeneic memory CD4 or CD8 T cells and fail to effectively support T-cell proliferation to the polyclonal activator, phytohemagglutinin, consistent with a defect in costimulation function. Although many costimulators are comparably expressed on both cell types, endothelial cells but not VSMC basally express OX40 ligand and upregulate inducible costimulator ligand in response to proinflammatory cytokines. OX40 ligand-transduced, but not control- or inducible costimulator ligand-transduced, VSMC acquire the capacity to stimulate allogeneic memory CD4 T cells to produce cytokines and to proliferate in the presence of supplemental l-tryptophan. OX40 ligand overexpression, although not essential, also enhances allogeneic memory CD8 T-cell responses to VSMC after l-tryptophan supplementation.
CONCLUSIONS: The inability of cultured VSMC to activate memory T cells results from a lack of essential costimulators, particularly OX40 ligand, in addition to indoleamine 2,3-dioxygenase-mediated tryptophan depletion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20539019      PMCID: PMC2924449          DOI: 10.1161/ATVBAHA.109.200758

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  30 in total

1.  OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection.

Authors:  M Kopf; C Ruedl; N Schmitz; A Gallimore; K Lefrang; B Ecabert; B Odermatt; M F Bachmann
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

2.  IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site.

Authors:  A J Dal Canto; P E Swanson; A K O'Guin; S H Speck; H W Virgin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  Human genetic evidence that OX40 is implicated in myocardial infarction.

Authors:  Massimiliano Ria; Per Eriksson; Susanna Boquist; Carl-Göran Ericsson; Anders Hamsten; Jacob Lagercrantz
Journal:  Biochem Biophys Res Commun       Date:  2005-11-28       Impact factor: 3.575

4.  B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha.

Authors:  M M Swallow; J J Wallin; W C Sha
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

Review 5.  Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium.

Authors:  J S Pober; T Collins; M A Gimbrone; P Libby; C S Reiss
Journal:  Transplantation       Date:  1986-02       Impact factor: 4.939

6.  Cardiac transplant atherosclerosis.

Authors:  M E Billingham
Journal:  Transplant Proc       Date:  1987-08       Impact factor: 1.066

7.  Differential activation of Th1 and Th2 CD4+ cells by murine brain microvessel endothelial cells and smooth muscle/pericytes.

Authors:  Z Fabry; M Sandor; T F Gajewski; J A Herlein; M M Waldschmidt; R G Lynch; M N Hart
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

8.  Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells.

Authors:  R N Salomon; C C Hughes; F J Schoen; D D Payne; J S Pober; P Libby
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

9.  The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.

Authors:  I Gramaglia; A Jember; S D Pippig; A D Weinberg; N Killeen; M Croft
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

10.  Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro.

Authors:  A G Murray; P Libby; J S Pober
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

View more
  13 in total

1.  Transforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cells.

Authors:  A H Lebastchi; S F Khan; L Qin; W Li; J Zhou; N Hibino; T Yi; D A Rao; J S Pober; G Tellides
Journal:  Am J Transplant       Date:  2011-08-03       Impact factor: 8.086

Review 2.  Immune effector mechanisms implicated in atherosclerosis: from mice to humans.

Authors:  Peter Libby; Andrew H Lichtman; Göran K Hansson
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

3.  Human placental pericytes poorly stimulate and actively regulate allogeneic CD4 T cell responses.

Authors:  Cheryl L Maier; Jordan S Pober
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-04       Impact factor: 8.311

4.  Reperfusion injury intensifies the adaptive human T cell alloresponse in a human-mouse chimeric artery model.

Authors:  Tai Yi; Birgit Fogal; Zhengrong Hao; Zuzana Tobiasova; Chen Wang; Deepak A Rao; Rafia S Al-Lamki; Nancy C Kirkiles-Smith; Sanjay Kulkarni; John R Bradley; Alfred L M Bothwell; William C Sessa; George Tellides; Jordan S Pober
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-03       Impact factor: 8.311

Review 5.  Participation of blood vessel cells in human adaptive immune responses.

Authors:  Jordan S Pober; George Tellides
Journal:  Trends Immunol       Date:  2011-10-24       Impact factor: 16.687

6.  Engineered zinc-finger proteins can compensate genetic haploinsufficiency by transcriptional activation of the wild-type allele: application to Willams-Beuren syndrome and supravalvular aortic stenosis.

Authors:  Pei Zhang; Angela Huang; Manuel Morales-Ruiz; Barry C Starcher; Yan Huang; William C Sessa; Laura E Niklason; Frank J Giordano
Journal:  Hum Gene Ther       Date:  2012-11       Impact factor: 5.695

7.  Immune cells and vasa vasorum in the tunica media of atherosclerotic coronary arteries.

Authors:  Ruda Zorc-Pleskovič; Aleš Pleskovič; Olga Vraspir-Porenta; Metka Zorc; Aleksandra Milutinović
Journal:  Bosn J Basic Med Sci       Date:  2018-08-01       Impact factor: 3.363

8.  Memory T Cells Mediate Cardiac Allograft Vasculopathy and are Inactivated by Anti-OX40L Monoclonal Antibody.

Authors:  Hao Wang; Zhixiang Zhang; Weijun Tian; Tong Liu; Hongqiu Han; Bertha Garcia; Xian C Li; Caigan Du
Journal:  Cardiovasc Drugs Ther       Date:  2014-04       Impact factor: 3.727

9.  Inhibition of microRNA-29 enhances elastin levels in cells haploinsufficient for elastin and in bioengineered vessels--brief report.

Authors:  Pei Zhang; Angela Huang; Jacopo Ferruzzi; Robert P Mecham; Barry C Starcher; George Tellides; Jay D Humphrey; Frank J Giordano; Laura E Niklason; William C Sessa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-17       Impact factor: 8.311

10.  Murine aortic smooth muscle cells acquire, though fail to present exogenous protein antigens on major histocompatibility complex class II molecules.

Authors:  Marcella Maddaluno; Neil MacRitchie; Gianluca Grassia; Armando Ialenti; John P Butcher; Paul Garside; James M Brewer; Pasquale Maffia
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.